{
    "organizations": [],
    "uuid": "6e558327c917aea68c1bb08a348c5edde7bc42c4",
    "author": "",
    "url": "https://www.reuters.com/article/brief-depomed-announces-closing-of-nucyn/brief-depomed-announces-closing-of-nucynta-commercialization-agreement-with-collegium-pharmaceutical-idUSFWN1P50DJ",
    "ord_in_thread": 0,
    "title": "BRIEF-Depomed Announces Closing Of Nucynta Commercialization Agreement With Collegium Pharmaceutical",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 08 PM / in 11 minutes BRIEF-Depomed Announces Closing Of Nucynta Commercialization Agreement With Collegium Pharmaceutical Reuters Staff \nJan 10 (Reuters) - Depomed Inc: \n* DEPOMED ANNOUNCES CLOSING OF NUCYNTA COMMERCIALIZATION AGREEMENT WITH COLLEGIUM PHARMACEUTICAL \n* DEPOMED INC - IN CONNECTION WITH CLOSING, CO RECEIVED AN UPFRONT $10 MILLION CASH PAYMENT FROM COLLEGIUM Source text for Eikon: Further company coverage:",
    "published": "2018-01-10T16:08:00.000+02:00",
    "crawled": "2018-01-10T16:22:35.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "minute",
        "announces",
        "closing",
        "nucynta",
        "commercialization",
        "agreement",
        "collegium",
        "pharmaceutical",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "depomed",
        "inc",
        "depomed",
        "announces",
        "closing",
        "nucynta",
        "commercialization",
        "agreement",
        "collegium",
        "pharmaceutical",
        "depomed",
        "inc",
        "connection",
        "closing",
        "co",
        "received",
        "upfront",
        "million",
        "cash",
        "payment",
        "collegium",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}